πŸ‡ΊπŸ‡Έ FDA
Patent

US 7632814

HYD1 peptides as anti-cancer agents

granted A61PA61P35/00

Quick answer

US patent 7632814 (HYD1 peptides as anti-cancer agents) held by The Regents of the University of California expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P35/00